EHR best practices: complying with new TMB documentation rules: Advanced Practice Providers: Rules, Regulations, and Physician Supervision (CME activity); New telemedicine rules; Complications from pain management procedure; Failure to diagnose pancreatitis; Windows 2003: the "biggest cyber security threat of 2015"
Other content in this Stream
A summary from the webinar “Release of medical records: Review of hot topics” presented on May 26, 2020.

What happens when a system failure brings down the EMR?

It is imperative to have a system in place that allows the release of complete, legible, and organized records from your medical office.

Failure to diagnose and treat; PIAA releases internal medicine closed claim data; EMR product evaluation tool now available from TMA

Failure to diagnose complications; PIAA releases general surgery closed claim data; EMR product evaluation tool now available from TMA

EMR risk management; Breast implant surgery; FDA recalls; Dissolute documentation? TMB rewrites rules for medical records (expired CME); TMB process; Failure to timely evaluate; Delay in reporting

Consider these guidelines to help reduce risk related to EHR systems
View part three of a three-part video series on improving physician/patient interactions.

TMLT's 2015 Texas legislative successes; Gaining the best value from your EHR (2.5-hour CME)

Electronic medical records and emerging changes to HIPAA; There is an "e" in medicine (CME); FDA restricts access to diabetes drug rosiglitazone (Avandia)

Failure to diagnose meningitis; PIAA releases national pediatric closed claim data; EMR product evaluation tool now available from TMA
Documentation pitfalls specifically related to electronic medical records (EMRs) and how to avoid them.

Drug name confusion; Electronic health records (exp. CME); Failure to communicate diagnosis of abdominal cancer; 2005 legislative update

The move to electronic medicine; Medical liability update; Failure/delay in diagnosis: Cancer; Botox parties, FDA prescription drug notices, changes in generic drug substitution laws